Media Newsroom of

HistoGeneX

Sint-Bavostraat 78
Wilrijk 2610

HistoGeneX Laboratories is a CAP, CLIA, and BELAC—accredited global laboratory system located in Antwerp, Belgium and Naperville, IL, USA. HistoGeneX serves pharma and biotech drug development sponsors worldwide.

HistoGeneX PD-L1 IHC and CD8 Work in ABACUS Trial Presented at ASCO 2018

Abacus Trial presented at ASCO 2018: Neo-adjuvant immunotherapy in bladder cancer. Complete pathological response in bladder wall is related with the PDL1 status and opens opportunities to understand biological mechanism of action. Thomas Powles (MD, Barts Cancer Institute, Queen Mary…

Login

Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login